Human trial of indigenous corona vaccine today: 10,000 registered in 10 hours in AIIMS Delhi, but only 100 healthy people between 18 and 55 years are getting vaccine


/ by Bodopress
Bodoprees: 20 Jul 2020
New Delhi. The human trials of the country's first indigenous vaccine are starting in AIIMS Delhi on Monday. AIIMS Delhi is one of the 14 institutes in the country, which has been approved by the ICMR for Phase I and II trials. The first phase of the vaccine trial will be at 375 volunteers. Of these, 100 volunteers will be from AIIMS. The trial will include healthy people only. Their age will be between 18 and 55 years. These will be volunteers who have not yet transitioned to COVID-19.

First approval to the people of Delhi-NCR

The Ethics Committee of AIIMS has approved the first human trial of Covaxin. More than 10 thousand people have registered in 10 hours to participate in the trial. At present, only the registration of people of Delhi-NCR will be approved.

According to Dr. Sanjay Rai, Professor, AIIMS Delhi, those who want to join the vaccine's human trial can register their name on mobile number 07428847499 or if they want to register, mail it to can do. The person on which the corona vaccine will be tested will have its first Kovid test. The trial will be on healthy people. Medical checkup gave the vaccine dose only after diseases related to blood, BP, kidney, and liver

1. Vaccine trial on animals completed
Ever since Bharat Biotech has announced the name of Covaxin, there is only one question on each side - when will this Coronavirus vaccine arrive? Scientists from the Indian Council of Medical Research (ICMR) and the National Institute of Virology, Pune are also working closely with Bharat Biotech to create this vaccine. Dr. Raman R. Gangakhedkar, the retired scientist of ICMR regarding vaccine trials, says that coaxing has been trialed on animals. Now there will be a human trial.

2. Treat a three-level trial as
In a conversation with Prasar Bharati, Dr. Gangakhedkar said that there are three levels of trials on humans.

First Stage: It is seen whether the vaccine is safe or not. At the same time, it is also seen whether antibodies are formed in the vaccine. Second stage: It is seen that there is no side effect of the vaccine. Whether there are any side effects within a year or 6 months. Third stage: During this time it is seen how many people are sick of renewed after giving the vaccine

The fourth stage process is not in trial mode. When they start giving vaccines to common people, it is seen that there are no side effects for the next two years. It is called post-marketing surveillance. A final decision is then taken on the vaccine.

3. How long can it take for the vaccine to reach the common people? On this question, Dr. Gangakhedkar said that till the time of Kovid, the vaccine trials took 7-10 years. Since the corona epidemic is spreading at a rapid pace, vaccine trials are being done in different ways to reduce the infection. It will take about one and a half to two years to be made in India too. India's first vaccine, the first phase of its trial will be completed by August 15. It will know whether antibodies are made by this vaccine and whether it is safe or not. 

Perhaps the company has thought that if this vaccine works, it will start its production, so that if it succeeds after the whole trial, then it will reach a large population in India soon. If this is not done then there can be damage.

4. China and American vaccines are also of India's standard
Dr. Gangakhedkar said that vaccine trials are conducted in different phases. Around 40 to 50 people are tried in Phase One.

Phase 2 consists of a trial of 200–250 people. In Phase 3, a large number of people participate. But whatever the results are, based on the calculation, samples are taken. He told me that there are only two vaccines that are in the Phase 2 trial. An Oxford-made vaccine is named Kox. The second is the Chinese vaccine, created by the Cyanovac company. Both of these are of the level of cocaine produced by Bharat Biotech.

5. First phase trial started in 12 hospitals

ICMR has selected 12 hospitals in the country for vaccine trials. These include AIIMS-Delhi, AIIMS Patna, King George Hospital-Visakhapatnam, PGI-Rohtak, Jeevan Rekha Hospital-Belagam, Gilurkar Multispeciality Hospital-Nagpur, Rana Hospital-Gorakhpur, SRM Hospital-Chennai, Nizam Institute of Medical Sciences-Hyderabad, Kalinga Hospital - Bhubaneswar, Prakhar Hospital - Kanpur and a hospital in Goa are also included.

No comments

More for You

Recent Popular Uploaded

What is the terms and conditions of a employee for upgrade in ASSAM ?

What is the terms and conditions of a employee for upgrade in ASSAM ? असम पुलिस ने एक मामले की जांच के लिए एक विशेष जांच दल का गठन किया है ज...

#SMILE: Short poems and feelings

#SMILE: Short poems and feelings
#SMILE: Short poems and feelings on the benefit of smiling.

Haila Huila, Rongjani De

Haila Huila, Rongjani De
New Bodo Album Released on YouTube "Bodo Press"

What is the Aronai ?

What is the Aronai ?
What is the Aronai ? Aronai is a small Scarf, used both by Men and Women.

BTC इलेक्शन पर एक बार नजर

BTC इलेक्शन पर एक बार नजर
One time look at BTC election, It was believed that on October 27, the election would be held after the end of Governor's rule.

भारी बस्ट और ब्रॉड पहनने वाली महिलाओं के लिए 10 सर्वश्रेष्ठ दख'ना डिजाइन।

Don't Miss
© all rights reserved
made with by templateszoo